SINO BIOPHARMACEUTICAL LIMITED

Analyst Reco. Sino Biopharmaceutical Limited

Equities

1177

KYG8167W1380

Delayed Hong Kong S.E. Other stock markets 04:08:06 2024-04-30 EDT			5-day change	1st Jan Change
2.7 ^HKD	-3.91%		+6.30%	-22.19%

04-30	Wall Street, Earnings, Federal Reserve Roil Asian Stock Markets	MT
04-25	Sino Biopharm Completes Phase I Study of Hepatitis B Drug	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nomura Adjusts Sino Biopharmaceutical’s Price Target to HK$6.16 From HK$6.63, Keeps at Buy	03-15	MT
Sino Biopharmaceutical Gets 'A' ESG Rating from MSCI	11-01	MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.63 From HK$7.43, Keeps at Buy	23-08-02	MT
Nomura Adjusts Sinobiopharma's Price Target to HK$7.43 From HK$7.78, Keeps at Buy	23-03-10	MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$7.5 From HK$8, Keeps at Buy	22-08-25	MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$7.78 From HK$8.19, Keeps at Buy	22-08-24	MT
Nomura Adjust Sino Biopharma’s Price Target to HK$8.19 From HK$8.53, Keeps at Buy	22-08-11	MT
UBS Adjusts Sino Biopharmaceutical's Price Target to HK$8 From HK$11.6, Keeps at Buy	22-05-06	MT
Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.53 From HK$9.38, Keeps at Buy	22-04-01	MT
SINO BIOPHARMACEUTICAL : Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.3 From HK$8.97, Keeps at Buy	21-03-30	MT
Market Chatter: Hong Kong's Vaccination Rate Plunges Amid Fears of COVID-19 Jab Complications	21-03-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer